Epigenomic alterations define lethal CIMP-positive ependymomas of infancy SC Mack, H Witt, RM Piro, L Gu, S Zuyderduyn, AM Stütz, X Wang, ... Nature 506 (7489), 445-450, 2014 | 629 | 2014 |
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations P Buczkowicz, C Hoeman, P Rakopoulos, S Pajovic, L Letourneau, ... Nature genetics 46 (5), 451-456, 2014 | 621 | 2014 |
Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors J Torchia, B Golbourn, S Feng, KC Ho, P Sin-Chan, A Vasiljevic, ... Cancer cell 30 (6), 891-908, 2016 | 223 | 2016 |
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma M Remke, V Ramaswamy, J Peacock, DJH Shih, C Koelsche, ... Acta neuropathologica 126, 917-929, 2013 | 199 | 2013 |
CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity T Spence, P Sin-Chan, D Picard, M Barszczyk, K Hoss, M Lu, SK Kim, ... Acta neuropathologica 128, 291-303, 2014 | 164 | 2014 |
ATM regulates 3-methylpurine-DNA glycosylase and promotes therapeutic resistance to alkylating agents S Agnihotri, K Burrell, P Buczkowicz, M Remke, B Golbourn, ... Cancer discovery 4 (10), 1198-1213, 2014 | 76 | 2014 |
Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors J Mangerel, A Price, P Castelo-Branco, J Brzezinski, P Buczkowicz, ... Acta neuropathologica 128, 853-862, 2014 | 56 | 2014 |
Spinal myxopapillary ependymomas demonstrate a Warburg phenotype SC Mack, S Agnihotri, KC Bertrand, X Wang, DJ Shih, H Witt, N Hill, ... Clinical Cancer Research 21 (16), 3750-3758, 2015 | 49 | 2015 |
Telomerase inhibition abolishes the tumorigenicity of pediatric ependymoma tumor-initiating cells M Barszczyk, P Buczkowicz, P Castelo-Branco, SC Mack, V Ramaswamy, ... Acta neuropathologica 128, 863-877, 2014 | 42 | 2014 |
Ependymoma LM Hoffman, AM Donson, I Nakachi, AM Griesinger, DK Birks, V Amani, ... Neuro Oncol 16 (Suppl_1), i17-i25, 2014 | 2 | 2014 |
Telomerase as a prognostic marker and therapeutic target in paediatric ependymoma M Barszczyk | 1 | 2013 |
Targeting the base excision repair pathway to overcome therapeutic resistance to alkylating agents in pediatric glioblastoma S Agnihotri, K Burrell, P Buczkowicz, M Remke, B Golbourn, ... Canadian Journal of Neurological Sciences 41 (s2), S5-S6, 2014 | | 2014 |
C19MC AMPLIFIED TUMOURS: A NEW HISTO-GENETIC AND DIAGNOSTIC ENTITY T Spence, D Picard, M Barszczyk, SK Kim, YS Ra, J Fangusaro, ... NEURO-ONCOLOGY 15, 170-170, 2013 | | 2013 |
EXPERIMENTAL THERAPEUTICS AND PHARMACOLOGY C Aaberg-Jessen, L Fogh, B Halle, V Jensen, N Brünner, B Kristensen, ... Neuro-oncology 15 (Suppl 3), iii37-iii61, 2013 | | 2013 |
PEDIATRICS CLINICAL RESEARCH R Antony, M Al-Rahawan, M Zagardo, M Gujrati, J Lin, A Broniscer, ... Neuro-oncology 15 (Suppl 3), iii165-iii172, 2013 | | 2013 |
Targeting DNA Damage Response Pathways to Overcome Alkylating Agent Resistance in Pediatric Glioblastoma C Hawkins, K Burrell, N Fernandez, I Clarke, M Barszczyk, N Sabha, ... JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 72 (6), 573-574, 2013 | | 2013 |
EFFECTIVE EPIGENETIC THERAPY FOR CIMP plus POSTERIOR FOSSA EPENDYMOMA S Mack, H Witt, N Jager, S Zuyderduyn, K Nethery-Brokx, L Garzia, ... NEURO-ONCOLOGY 15, 22-22, 2013 | | 2013 |
Targeting DNA Damage Response Pathways to Overcome Alkylating Agent Resistance in Pediatric Glioblastoma S Agnihotri, K Burrell, N Fernandez, B Golbourn, I Clarke, M Barrzczyk, ... NEURO-ONCOLOGY 15, 27-28, 2013 | | 2013 |
Telomerase inhibition induces growth arrest in paediatric ependymoma M Barszczyk, P Buczkowicz, P Castelo-Branco, S Mack, K Nethery-Brokx, ... NEURO-ONCOLOGY 15, 7-7, 2013 | | 2013 |
TELOMERASE INHIBITION INDUCES GROWTH ARREST IN PAEDIATRIC EPENDYMOMA M Barszczyk, P Buczkowicz, A Morrison, U Tabori, C Hawkins NEURO-ONCOLOGY 14, 39-39, 2012 | | 2012 |